• Explore /
  • Poster
  • / A pilot study of AMP-224 – a PD-1 inhibitor – in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic colorectal cancer.

A pilot study of AMP-224 – a PD-1 inhibitor – in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic colorectal cancer.

Abstract Poster

Authors

null

Austin G. Duffy

National Cancer Institute at the National Institutes of Health, Bethesda, MD

Austin G. Duffy , Oxana V. Makarova-Rusher , Suzanne Fioravanti , Melissa Walker , Aradhana Venkatesan , Nadine Abi-Jaoudeh , Bradford J. Wood , Deborah E. Citrin , Tim F. Greten

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Clinical Trial Registration Number

awaited

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr TPS788)

DOI

10.1200/jco.2015.33.3_suppl.tps788

Abstract #

TPS788

Poster Bd #

F26

Abstract Disclosures

Similar Posters

First Author: Austin G. Duffy

First Author: Jiwon Lee

First Author: Georg Martin Haag

First Author: Mehmet Akce